In the BioHarmony Drug Report Database

"Preview" Icon

Econazole

Ecoza, Spectazole, Ketoconazole HRA (econazole) is a small molecule pharmaceutical. Econazole was first approved as Ecoza on 1982-12-23. It is used to treat cutaneous candidiasis, mycoses, tinea pedis, and tinea versicolor in the USA. It has been approved in Europe to treat cushing syndrome. It is known to target transient receptor potential cation channel subfamily V member 5 and transient receptor potential cation channel subfamily M member 2. Econazole nitrate’s patent is valid until 2031-08-08 (FDA).

 

Trade Name

 

Ketoconazole HRA
 

Common Name

 

econazole
 

ChEMBL ID

 

CHEMBL808
 

Indication

 

cushing syndrome, cutaneous candidiasis, mycoses, tinea pedis, tinea versicolor
 

Drug Class

 

Systemic antifungals (miconazole type)

Image (chem structure or protein)

Econazole structure rendering